17-31330397-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP2PP3
The NM_001042492.3(NF1):āc.5711A>Gā(p.Asn1904Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1904T) has been classified as Pathogenic.
Frequency
Consequence
NM_001042492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.5711A>G | p.Asn1904Ser | missense_variant | 39/58 | ENST00000358273.9 | NP_001035957.1 | |
NF1 | NM_000267.3 | c.5648A>G | p.Asn1883Ser | missense_variant | 38/57 | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NF1 | ENST00000358273.9 | c.5711A>G | p.Asn1904Ser | missense_variant | 39/58 | 1 | NM_001042492.3 | ENSP00000351015.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251290Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135810
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461616Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727122
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 07, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been reported as de novo in an infant who also carried a de novo SOX9 variant (PMID: 27959697), therefore it is uncertain if the c.5648A>G NF1 variant is causative of disease in this individual. ClinVar contains an entry for this variant (Variation ID: 220757). This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with serine at codon 1883 of the NF1 protein (p.Asn1883Ser). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and serine. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Baylor Genetics | May 01, 2016 | Our laboratory reported two molecular diagnoses in NF1 (NM_000267.3:c.5648A>G) and SOX9 (NM_000346.3:c.1427T>C) in an individual with Pierre Robin Sequence, dysmorphic features, atrial septal defect with patent ductus arteriosus, hypertrophic cardiomyopathy, multiple cafe au lait spots, deep creases to palms and soles, a history of prematurity and a perinatal course complicated by anhydramnios, preterm premature rupture of membranes, pre-eclampsia and respiratory failure. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at